LINC01397: A Potential Drug Target and Biomarker (G104355139)

Target Name: LINC01397

NCBI ID: G104355139

LINC01397

Other Name(s): Long intergenic non-protein coding RNA 1397 | long intergenic non-protein coding RNA 1397

LINC01397: A Potential Drug Target and Biomarker

LINC01397 is a non-coding RNA (ncRNA) that has been identified in various cellular contexts. It has been characterized as a long intergenic non-protein coding RNA (lncRNA), which means it is not a protein but rather a RNA molecule that functions as a scaffold to organize the expression of genes in the cell. LINC01397 has been shown to play a role in various cellular processes, including cell adhesion, migration, and transcriptional regulation.

The search for potential drug targets and biomarkers is a critical aspect of modern medicine. Drug targets are proteins that are targeted by drugs to induce specific cellular responses, while biomarkers are physiological or biochemical changes that occur in the body that can be used as indicators of disease. LINC01397 has the potential to be a drug target or biomarker due to its unique function and the involvement in various cellular processes.

Drug Target Potential

LINC01397 has been shown to interact with various proteins, including the transcription factor, NF-kappa-B, and the protein kinase, TP53. These interactions suggest that LINC01397 could be a potential drug target. The TP53 gene is a well-established cancer suppressor gene that plays a crucial role in maintaining genomic stability and repair. LINC01397 has been shown to regulate the activity of TP53, which could make it a potential drug target for cancer treatment.

In addition to its potential role in cancer, LINC01397 has also been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of healthy tissues. For example, LINC01397 has been shown to be involved in the regulation of cell adhesion, which is critical for the development and maintenance of tissues and organs. LINC01397 has also been shown to be involved in the regulation of cell migration, which is critical for the formation of tissues and organs during development.

Biomarker Potential

The involvement of LINC01397 in various cellular processes also suggests that it may have the potential to serve as a biomarker for various diseases. For example, LINC01397 has been shown to be involved in the regulation of cell adhesion, which is often disrupted in diseases such as cancer, neurodegenerative diseases, and developmental disorders. LINC01397 has also been shown to be involved in the regulation of cell migration, which is often disrupted in diseases such as cancer, neurodegenerative diseases, and developmental disorders.

Conclusion

In conclusion, LINC01397 is a potential drug target and biomarker due to its unique function and the involvement in various cellular processes. Its potential as a drug target is further supported by its interaction with the transcription factor, NF-kappa-B, and the protein kinase, TP53. Its potential as a biomarker is further demonstrated by its involvement in the regulation of cell adhesion and cell migration, which are critical for the development and maintenance of healthy tissues. Further research is needed to fully understand the role of LINC01397 in various cellular processes and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1397

The "LINC01397 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01397 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets